DRD2 and hematologic disorder: ONC201 is a dopamine receptor D2 (DRD2) antagonist and caseinolytic mitochondrial matrix peptidase proteolytic subunit P (ClpP) agonist that induces cancer cell apoptosis, cell cycle arrest, and antiproliferative effects, including effects on solid tumors and hematological malignancies [3].